D. Gulhan

33.6k total citations
30 papers, 794 citations indexed

About

D. Gulhan is a scholar working on Molecular Biology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, D. Gulhan has authored 30 papers receiving a total of 794 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 14 papers in Cancer Research and 10 papers in Pathology and Forensic Medicine. Recurrent topics in D. Gulhan's work include Cancer Genomics and Diagnostics (13 papers), PARP inhibition in cancer therapy (8 papers) and Genetic factors in colorectal cancer (7 papers). D. Gulhan is often cited by papers focused on Cancer Genomics and Diagnostics (13 papers), PARP inhibition in cancer therapy (8 papers) and Genetic factors in colorectal cancer (7 papers). D. Gulhan collaborates with scholars based in United States, United Kingdom and Switzerland. D. Gulhan's co-authors include Peter J. Park, Giorgio Melloni, Isidro Cortés‐Ciriano, Jake June-Koo Lee, Joshua Cook, Kevin M. Haigis, Krishna Rajagopal, Daniel Pablos, José Guilherme Milhano and Jorge Casalderrey-Solana and has published in prestigious journals such as Nature, Nature Communications and Nature Genetics.

In The Last Decade

D. Gulhan

27 papers receiving 789 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D. Gulhan United States 12 452 301 288 133 96 30 794
G.B. Mills United States 11 492 1.1× 253 0.8× 249 0.9× 54 0.4× 117 1.2× 19 859
Ulrica Westermark Sweden 11 682 1.5× 285 0.9× 292 1.0× 115 0.9× 8 0.1× 19 984
Christoffer Flensburg Australia 11 251 0.6× 111 0.4× 151 0.5× 34 0.3× 144 1.5× 18 696
Steven Buechler United States 15 263 0.6× 123 0.4× 117 0.4× 28 0.2× 10 0.1× 45 712
Penelope DeCarolis United States 13 443 1.0× 196 0.7× 259 0.9× 54 0.4× 15 0.2× 17 873
Janapriya Saha United States 15 510 1.1× 180 0.6× 174 0.6× 41 0.3× 6 0.1× 24 818
Yan‐Yi Jiang China 21 719 1.6× 259 0.9× 312 1.1× 35 0.3× 6 0.1× 37 1.0k
Katsutoshi Sato Japan 12 187 0.4× 172 0.6× 94 0.3× 14 0.1× 36 0.4× 23 430
Cläre von Neubeck Germany 18 330 0.7× 301 1.0× 189 0.7× 30 0.2× 8 0.1× 48 1.1k
Andrea Rosner United States 12 569 1.3× 341 1.1× 310 1.1× 96 0.7× 3 0.0× 16 929

Countries citing papers authored by D. Gulhan

Since Specialization
Citations

This map shows the geographic impact of D. Gulhan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. Gulhan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. Gulhan more than expected).

Fields of papers citing papers by D. Gulhan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D. Gulhan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. Gulhan. The network helps show where D. Gulhan may publish in the future.

Co-authorship network of co-authors of D. Gulhan

This figure shows the co-authorship network connecting the top 25 collaborators of D. Gulhan. A scholar is included among the top collaborators of D. Gulhan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. Gulhan. D. Gulhan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jin, Hu, et al.. (2024). Accurate and sensitive mutational signature analysis with MuSiCal. Nature Genetics. 56(3). 541–552. 8 indexed citations
2.
Watson, Emma V., Jake June-Koo Lee, D. Gulhan, et al.. (2024). Chromosome evolution screens recapitulate tissue-specific tumor aneuploidy patterns. Nature Genetics. 56(5). 900–912. 16 indexed citations
3.
Onozato, Maristela L., A. John Iafrate, Daniel Hicks, et al.. (2024). ERBB2/HOXB13 co-amplification with interstitial loss of BRCA1 defines a unique subset of breast cancers. Breast Cancer Research. 26(1). 185–185. 1 indexed citations
4.
5.
Kim, Yoo‐Na, D. Gulhan, Hu Jin, Dominik Głodzik, & Peter J. Park. (2024). Recent Advances in Genomic Approaches for the Detection of Homologous Recombination Deficiency. Cancer Research and Treatment. 56(4). 975–990. 3 indexed citations
6.
Lee, Jake June-Koo, Youngsook L. Jung, Taek-Chin Cheong, et al.. (2023). ERα-associated translocations underlie oncogene amplifications in breast cancer. Nature. 618(7967). 1024–1032. 62 indexed citations
7.
Konstantinopoulos, Panagiotis A., Su–Chun Cheng, Alexandre André Balieiro Anastácio da Costa, et al.. (2023). Randomized phase 2 study of gemcitabine with or without ATR inhibitor berzosertib in platinum-resistant ovarian cancer: Final overall survival (OS) and biomarker analyses.. Journal of Clinical Oncology. 41(16_suppl). 5512–5512. 3 indexed citations
8.
Lv, Lin, D. Gulhan, Haishuai Wang, et al.. (2023). De novo identification of expressed cancer somatic mutations from single-cell RNA sequencing data. Genome Medicine. 15(1). 115–115. 3 indexed citations
9.
Luquette, Lovelace J., Michael B. Miller, Zinan Zhou, et al.. (2022). Single-cell genome sequencing of human neurons identifies somatic point mutation and indel enrichment in regulatory elements. Nature Genetics. 54(10). 1564–1571. 50 indexed citations
10.
Batalini, Felipe, D. Gulhan, Madeline Polak, et al.. (2022). Mutational Signature 3 Detected from Clinical Panel Sequencing is Associated with Responses to Olaparib in Breast and Ovarian Cancers. Clinical Cancer Research. 28(21). 4714–4723. 22 indexed citations
11.
Ghisoni, Eleonora, Fabrizio Benedetti, Paula Cunnea, et al.. (2022). 27MO Integrated digital pathology and single-cell analysis identify the spatial and temporal evolution of immune cells networks in epithelial ovarian cancer. Annals of Oncology. 33. S395–S395. 1 indexed citations
12.
Cook, Joshua, Giorgio Melloni, D. Gulhan, Peter J. Park, & Kevin M. Haigis. (2021). The origins and genetic interactions of KRAS mutations are allele- and tissue-specific. Nature Communications. 12(1). 1808–1808. 109 indexed citations
13.
Cook, Joshua, Giorgio Melloni, D. Gulhan, Peter J. Park, & Kevin M. Haigis. (2021). The origins and genetic interactions of KRAS mutations are allele- and tissue-specific. Zenodo (CERN European Organization for Nuclear Research). 2 indexed citations
14.
Cortés‐Ciriano, Isidro, D. Gulhan, Jake June-Koo Lee, Giorgio Melloni, & Peter J. Park. (2021). Computational analysis of cancer genome sequencing data. Nature Reviews Genetics. 23(5). 298–314. 65 indexed citations
15.
Färkkilä, Anniina, Alfredo Rodríguez, Jaana Oikkonen, et al.. (2021). Heterogeneity and Clonal Evolution of Acquired PARP Inhibitor Resistance in TP53- and BRCA1 -Deficient Cells. Cancer Research. 81(10). 2774–2787. 19 indexed citations
16.
Batalini, Felipe, D. Gulhan, Madeline Polak, et al.. (2021). Abstract 156: Mutational signature 3 predicts responses to olaparib plus buparlisib in triple-negative breast cancer and high-grade serous ovarian cancer. Cancer Research. 81(13_Supplement). 156–156.
17.
Konstantinopoulos, Panagiotis A., Alexandre André Balieiro Anastácio da Costa, D. Gulhan, et al.. (2021). A Replication stress biomarker is associated with response to gemcitabine versus combined gemcitabine and ATR inhibitor therapy in ovarian cancer. Nature Communications. 12(1). 5574–5574. 44 indexed citations
18.
Armesto, N., D. Gulhan, & José Guilherme Milhano. (2020). Kinematic bias on centrality selection of jet events in pPb collisions at the LHC. LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas). 2 indexed citations
19.
Bohrson, Craig L., Alison R. Barton, Michael A. Lodato, et al.. (2019). Linked-read analysis identifies mutations in single-cell DNA-sequencing data. Nature Genetics. 51(4). 749–754. 63 indexed citations
20.
Gulhan, D., Jake June-Koo Lee, Giorgio Melloni, Isidro Cortés‐Ciriano, & Peter J. Park. (2019). Detecting the mutational signature of homologous recombination deficiency in clinical samples. Nature Genetics. 51(5). 912–919. 186 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G.B. Mills Breakdown of academic impact, for papers by Ulrica Westermark Breakdown of academic impact, for papers by Christoffer Flensburg Breakdown of academic impact, for papers by Steven Buechler Breakdown of academic impact, for papers by Penelope DeCarolis Breakdown of academic impact, for papers by Janapriya Saha Breakdown of academic impact, for papers by Yan‐Yi Jiang Breakdown of academic impact, for papers by Katsutoshi Sato Breakdown of academic impact, for papers by Cläre von Neubeck Breakdown of academic impact, for papers by Andrea Rosner
Rankless by CCL
2026